Geoffrey R Oxnard

基本信息

Career Trajectory

Bio

The aims of Dr. Oxnard’s research are to develop clinical applications for cancer genotyping technologies to advance precision cancer care.

Dr. Oxnard has published extensively on sensitivity and resistance to EGFR kinase inhibitors in lung cancer with a focus on the clinical biology of the EGFR T790M mutation. More recently his research has focused on genomic analysis of plasma cell-free DNA as a diagnostic to assist in treatment planning, response monitoring, and cancer detection.

Research Interests

Papers共 580 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Tumor Mutational Burden and Survival on Immune Checkpoint Inhibition in >8000 Patients Across 24 Cancer Types

David R Gandara, Neeraj Agarwal, Shilpa Gupta, Samuel J Klempner,Miles C Andrews,Amit Mahipal, Vivek Subbiah,Ramez N Eskander,David P Carbone, Jonathan W Riess, Sarah Sammons,Jeremy Snider, Lilia Bouzit,Cheryl Cho-Phan, Megan Price,Gerald Li,Julia C F Quintanilha, Richard Sheng Poe Huang,Jeffrey S Ross, David Fabrizio,Geoffrey R Oxnard,Ryon P Graf

Journal for immunotherapy of cancerno. 2 (2025)

Cited0Views0WOSBibtex

Round-Robin Comparison of RET Rearrangement Detection in Ctdna: A Novel Method for Limited Clinical Samples

Cloud P Paweletz, Alison Urvalek, Minh Ha,Kavita Garg,Aimee Bence Lin,Anna M Szpurka, Anthony Sireci,Geoffrey R Oxnard,Pasi A Janne

Clinical cancer research an official journal of the American Association for Cancer Researchno. 12 (2025): 2406-2412

Cited0Views0WOSBibtex

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, from the LIBRETTO-001 Phase I/II Trial

Oliver Gautschi,Keunchil Park,Benjamin J Solomon,Pascale Tomasini,Herbert H Loong,Filippo De Braud,Koichi Goto,Patrick Peterson,Scott Barker, Katherine Liming,Geoffrey R Oxnard,Bente Frimodt-Moller,Alexander Drilon

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 15 (2025): 1758-1764

Cited0Views0WOSBibtex

Benefits of Combining Circulating Tumor DNA with Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study

JCO precision oncology (2025): e2400283-e2400283

Cited0Views0WOSBibtex

Ctdna Clearance As an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical Trials

Hillary S Andrews, Nevine Zariffa,Katherine K Nishimura, Stephanie H Choi,Shibing Deng, Megan Eisele,Carin R Espenschied, Emily M Goren, Minakshi Guha, Samuel Hong,Dilafruz Juraeva, Nicole Krämer, Li Liu,Jean-Francois Martini, Brittany A McKelvey,Geoffrey R Oxnard,Gary A Pestano,Lynne Poole,Adam Rosenthal, Anna M Szpurka,Diana Merino Vega, Christine Ward, Sameera R Wijayawardana,Antje Hoering, Mark D Stewart, Jeff D Allen

Clinical cancer research an official journal of the American Association for Cancer Researchno. 11 (2025): 2162-2172

Cited0Views0WOSBibtex

Efficacité Et Tolérance De L’olomorasib (LY3537982), Un Inhibiteur De KRAS G12C (g12ci) De Deuxième Génération, Combiné Au Pembrolizumab Chez Des Patients Atteints D’un CBNPC Avancé Avec Mutation KRAS G12C

A. Hollebecque,T.F. Burns, K. Dragnev, Y. Fujiwara, Y.R. Murciano-Goroff, D.H. Lee, T. Koyama, P. Cassier, A. Italiano,R.S. Heist, J.Y. Han, D. Deming, A. Spira, J. Sabari,M.J. Chisamore, A. Fink, A. Chen, M.D. Willard,G.R. Oxnard, N.R. Ammakkanavar

Revue des Maladies Respiratoires Actualités（2025）

Cited0Views0Bibtex

ESR1 mutations (ESR1mut) in HR(+)HER2(-)patients with metastatic breast cancer (MBC): prevalence along treatment course and predictive value for endocrine therapy (ET) resistance in real-world practice

Manali Bhave,Julia Quintanilha,Ryon Graf, Takara Scott,Hanna Tukachinsky,Gerald Li,Alexa Schrock,Geoffrey Oxnard,Mia Levy,Kevin Kalinsky

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Supplementary Figure 4 from Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation

Christian D. Rolfo,Russell W. Madison,Lincoln W. Pasquina, Derek W. Brown,Yanmei Huang,Jason D. Hughes,Ryon P. Graf,Geoffrey R. Oxnard,Hatim Husain

crossref（2024）

Cited0Views0Bibtex

Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib

Julia K. Rotow,Jessica K. Lee,Russell W. Madison,Geoffrey R. Oxnard,Pasi A. Janne,Alexa B. Schrock

JOURNAL OF THORACIC ONCOLOGYno. 2 (2024): 227-239

Cited12Views0WOSBibtex

Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma

Miles C. Andrews,Gerald Li,Ryon P. Graf,Virginia A. Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke,Mark Shackleton,Mahesh Iddawela,Geoffrey R. Oxnard,Richard S. P. Huang

JCO PRECISION ONCOLOGY (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Associate Professor

Papers共 580 篇Author StatisticsCo-AuthorSimilar Experts